Targeting silibinin in the antiproliferative pathway

Area of Science:

• Natural product chemistry
• Cancer biology
• Pharmacology

Background:

• Cancer chemotherapy often fails and causes severe toxicity.
• Silibinin, a flavonoid from milk thistle, is gaining attention for its anticancer properties.
• Silibinin exhibits anticancer effects including growth inhibition, anti-angiogenesis, and chemosensitization.

Purpose of the Study:

• To review recent advancements in silibinin's role in regulating anticancer proliferative signaling pathways.
• To focus on literature published within the last 3-5 years.

Main Methods:

• Literature review of studies on silibinin and cancer signaling pathways.
• Analysis of silibinin's effects on receptor tyrosine kinases, androgen receptor, STATs, NF-kappaB, cell cycle, and apoptosis.

Main Results:

• Silibinin regulates multiple cancer cell proliferative pathways.
• Key pathways targeted by silibinin include receptor tyrosine kinases, androgen receptor, STATs, NF-kappaB, cell cycle, and apoptosis.
• Silibinin demonstrates significant antiproliferative effects in various cancer cells.

Conclusions:

• Silibinin's antiproliferative effects are mediated through specific molecular pathways.
• Targeting proliferative pathways with silibinin presents a novel strategy for cancer chemoprevention and chemotherapy.
• Silibinin offers a potentially less toxic and effective approach to cancer treatment.